Search

PerkinElmer Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

0

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

Pagrindiniai rodikliai

By Trading Economics

Pajamos

13M

53M

Pardavimai

19M

730M

P/E

Sektoriaus vid.

75.05

51.78

Pelnas, tenkantis vienai akcijai

1.37

Dividendų pajamingumas

0.18

Pelno marža

7.329

Darbuotojai

11,000

EBITDA

8.8M

189M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+4.65% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.18%

1.96%

Kitas uždarbis

2027-02-01

Kitas dividendų mokėjimo data

2026-11-13

Kita Ex Dividend data

2027-01-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

4.1B

17B

Ankstesnė atidarymo kaina

0

Ankstesnė uždarymo kaina

0

PerkinElmer Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-11-04 21:05; UTC

News
Correlated Moves

Revvity, Inc. declines as JP Morgan, Barclays, and RBC Capital raise price targets to $160, $175, and $172, respectively, amid broader market conditions.

2026-11-03 23:06; UTC

Revvity, Inc. shares traded modestly lower in after-market hours on Tuesday, remaining above its 20-day moving average and near the upper end of its one-month range.

2026-11-02 23:31; UTC

In after-market trading, Revvity, Inc. has gained ground, recovering from earlier weakness to reach a peak just before the latest observation.

2026-10-30 21:51; UTC

News

Revvity, Inc. declared a quarterly dividend of $0.07 per share, payable on February 12, 2027, to shareholders of record as of January 22, 2027.

2026-10-29 20:07; UTC

Revvity, Inc. shares are advancing, marking nine consecutive days of higher closes and peaking significantly above Wednesday's close.

2026-10-28 20:06; UTC

Correlated Moves

Revvity, Inc. shares are advancing, continuing an upward trend since Tuesday, despite earlier pulling back from a session high, remaining above its 20-day moving average.

2026-10-26 19:16; UTC

Revvity Inc shares are advancing, continuing a trend of modest gains since Friday's close, despite an earlier pullback from a session high.

2026-10-23 20:13; UTC

Revvity Inc shares are trading modestly higher in after-market hours, continuing a trend of five consecutive sessions finishing higher.

2026-10-22 21:41; UTC

Revvity Inc shares have declined in after-market trading, reaching their lowest point of the day after moving from a slight loss post-close.

2026-10-21 20:07; UTC

Correlated Moves

Revvity Inc shares are advancing, continuing an upward trend since Tuesday, while Charles River Laboratories is sharply higher with increased trading activity and volume.

2026-10-20 20:02; UTC

News

Revvity Inc. launches its AI-first Signals LabGistics solution to streamline scientific workflows in pharma and biotech, with positive outlook from Citrini Research.

2026-10-19 19:36; UTC

Correlated Moves

Revvity Inc shares are declining, facing speculation around Thermo Fisher Scientific Inc's upcoming earnings report, despite earlier reaching a session high.

2026-10-16 21:02; UTC

Revvity Inc's shares are declining in after-market trading, hitting their lowest level since Friday's close amid ongoing price weakness.

2026-10-15 23:46; UTC

Revvity Inc's shares declined modestly in after-market trading, following earlier gains, and remain near the upper end of their one-month range.

2026-10-14 23:46; UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a decline that began after Wednesday's close.

2026-10-13 20:13; UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a downward trend since Tuesday's close amid unusual weakness during the session.

2026-10-12 19:51; UTC

Revvity Inc shares are advancing, continuing a higher trend since Friday's close, despite currently trading lower in today's session.

2026-10-08 20:06; UTC

Revvity Inc shares are declining, having pulled back from earlier gains amid a broader market trend lower since Wednesday's close.

2026-10-07 19:25; UTC

News

Barclays raised Revvity Inc's price target to $160.00 from $115.00, maintaining an Equal-weight rating, as the stock trades modestly higher.

2026-10-06 22:41; UTC

News

Revvity Inc shares declined in after-market trading despite an Outperform rating from William Blair, closing at their lowest point since Tuesday.

2026-10-05 19:21; UTC

Correlated Moves

Revvity Inc is advancing, likely influenced by a significant rise in shares of Charles River Laboratories, reaching its best cumulative return since Friday's close.

2026-10-02 19:45; UTC

News

Revvity Inc. will release Q3 2026 financial results on November 3, 2026, contributing to the stock's upward movement today, despite a slight retracement.

2026-10-01 20:03; UTC

Revvity Inc shares fell sharply from an early peak, currently trading near their lowest point of the day despite being above the 20-day moving average.

2026-09-30 21:02; UTC

Revvity Inc is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month range.

2026-09-29 19:36; UTC

Revvity Inc is trading higher, reaching a peak return since Monday's close and maintaining a position above its 20-day moving average.

2026-09-28 20:20; UTC

Revvity Inc's shares are trading modestly lower in after-market hours, shifting from a slight gain to a loss since Monday's close.

2026-09-25 20:01; UTC

Revvity Inc shares fell sharply, pulling back from earlier gains and currently trading below Thursday's close despite being above its 20-day moving average.

2026-09-24 23:11; UTC

Revvity Inc has advanced modestly in after-market trading, remaining significantly above its 20-day moving average and showing notable gains over the past month.

2026-09-23 20:07; UTC

Revvity Inc shares fell sharply, settling below Tuesday's close after an early peak, though remaining above the 20-day moving average.

2026-09-22 19:31; UTC

Revvity Inc shares fell sharply after briefly gaining earlier, but remain above their 20-day moving average and near the upper end of their one-month range.

Akcijų palyginimas

Kainos pokytis

PerkinElmer Inc Prognozė

Kainos tikslas

By TipRanks

4.65% į viršų

12 mėnesių prognozė

Vidutinis 166.846 USD  4.65%

Aukščiausias 190 USD

Žemiausias 120 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines PerkinElmer Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

15 ratings

6

Pirkti

9

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat